MPW - Medical Properties Trust, Inc.
NYSE
->
Real Estate
->
REIT—Healthcare Facilities
Birmingham,
United States
Type: Equity
MPW price evolution
MPW
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jun 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $250.02 | $340.06 | $324.05 | $302.32 |
| Short term investments | ||||
| Net receivables | $635.99 | $788.76 | $957.23 | $980.42 |
| Inventory | ||||
| Total current assets | $886 | $1128.82 | $1103.63 | $1113.23 |
| Long term investments | ||||
| Property, plant & equipment | $16623.26 | $16858.74 | $13814.59 | $14695.26 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | $3545.71 | $3569.04 | $3498.63 | $3093.3 |
| Total assets | $18304.84 | $19004.88 | $19204.38 | $19650.16 |
| Current liabilities | ||||
| Accounts payable | $412.18 | $375.89 | $444.93 | $595.27 |
| Deferred revenue | $37.96 | $32.28 | $49.77 | $29.39 |
| Short long term debt | ||||
| Total current liabilities | $568.78 | $530.11 | $602.34 | $739.36 |
| Long term debt | $10064.24 | $10157.08 | $10237.56 | $10438.15 |
| Total noncurrent liabilities | ||||
| Total debt | $10220.84 | $10311.3 | $10394.97 | $10582.24 |
| Total liabilities | $10673.24 | $10720.35 | $10889.66 | $11206.9 |
| Shareholders' equity | ||||
| Retained earnings | -$971.81 | -$215.06 | -$241.3 | -$25.41 |
| Other shareholder equity | $42.5 | -$59.78 | $6.68 | -$74.92 |
| Total shareholder equity | $7631.6 | $8284.53 | $8313.81 | $8441.68 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $250.02 | $235.67 | $459.23 | $549.88 |
| Short term investments | ||||
| Net receivables | $635.99 | $787.17 | $784.75 | $536.67 |
| Inventory | ||||
| Total current assets | $886 | $1022.83 | $1187.75 | $4035.56 |
| Long term investments | $1123.62 | |||
| Property, plant & equipment | $16623.26 | $17667.3 | $16432.67 | $13504.4 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | $3545.71 | $3170.61 | $2509.68 | $1981.99 |
| Total assets | $18304.84 | $19658 | $20519.8 | $16829.01 |
| Current liabilities | ||||
| Accounts payable | $412.18 | $621.32 | $607.79 | $438.75 |
| Deferred revenue | $37.96 | $27.73 | $25.56 | $36.18 |
| Short long term debt | ||||
| Total current liabilities | $568.78 | $767.45 | $763.86 | $446.06 |
| Long term debt | $10064.24 | $10268.41 | $11284.71 | $8865.46 |
| Total noncurrent liabilities | ||||
| Total debt | $10220.84 | $10414.54 | $11440.77 | $9010.23 |
| Total liabilities | $10673.24 | $11065.16 | $12074.13 | $9485.16 |
| Shareholders' equity | ||||
| Retained earnings | -$971.81 | $116.28 | -$87.69 | -$71.41 |
| Other shareholder equity | $42.5 | -$59.18 | -$36.73 | -$51.32 |
| Total shareholder equity | $7631.6 | $8592.84 | $8440.19 | $7338.53 |
| (in millions $) | 31 Jan 2024 | 30 Oct 2023 | 30 Jun 2023 | 1 May 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | -$122.38 | $306.58 | $337.39 | |
| Cost of revenue | $389.08 | |||
| Gross Profit | -$125.68 | $300.09 | -$51.68 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $35.6 | |||
| Total operating expenses | $107.44 | $115.91 | $35.6 | |
| Operating income | -$87.29 | |||
| Income from continuing operations | ||||
| EBIT | -$85.83 | |||
| Income tax expense | $3.98 | $10.06 | -$148.26 | |
| Interest expense | -$123.21 | -$94.58 | $104.47 | |
| Net income | ||||
| Net income | -$664.29 | $116.4 | -$42.04 | |
| Income (for common shares) | -$42.04 | |||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $871.8 | $1542.85 | $1249.24 | |
| Cost of revenue | $378.67 | $289.13 | ||
| Gross Profit | $830.23 | $1164.18 | $960.1 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $160.49 | $131.66 | ||
| Total operating expenses | $748.95 | $160.49 | $131.66 | |
| Operating income | $1003.68 | $828.44 | ||
| Income from continuing operations | ||||
| EBIT | $1317.53 | $791.23 | ||
| Income tax expense | -$130.68 | $55.9 | $31.06 | |
| Interest expense | -$397.2 | $359.04 | $328.73 | |
| Net income | ||||
| Net income | -$558.12 | $902.6 | $431.45 | |
| Income (for common shares) | $902.6 | $431.45 | ||
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$663.94 | $116.71 | -$42.04 | $32.79 |
| Operating activities | ||||
| Depreciation | $79.93 | $80.65 | $367.97 | $87.59 |
| Business acquisitions & disposals | -$162.29 | -$72.9 | ||
| Stock-based compensation | $3.53 | $11.45 | $6.44 | $11.83 |
| Total cash flows from operations | $135.42 | $158.19 | $76.53 | $135.65 |
| Investing activities | ||||
| Capital expenditures | $198.14 | -$19.25 | $391.82 | -$81.8 |
| Investments | -$27.92 | -$42.41 | $162.29 | $171.88 |
| Total cash flows from investing | $170.22 | -$61.66 | $391.82 | $17.18 |
| Financing activities | ||||
| Dividends paid | -$91.23 | -$173.85 | -$173.72 | -$176.58 |
| Sale and purchase of stock | ||||
| Net borrowings | -$311.89 | $107.11 | -$297.92 | $95.7 |
| Total cash flows from financing | -$402.73 | -$66.66 | -$461.82 | -$89.13 |
| Effect of exchange rate | $7.16 | -$13.95 | $15.26 | $2.93 |
| Change in cash and equivalents | -$97.09 | $29.88 | $6.53 | $63.7 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$556.48 | $902.6 | $656.02 | $431.45 |
| Operating activities | ||||
| Depreciation | $616.13 | $345.58 | $333.78 | $275.95 |
| Business acquisitions & disposals | -$235.19 | -$1332.96 | -$5350.24 | -$4249.18 |
| Stock-based compensation | $33.25 | $49.42 | $52.11 | $47.15 |
| Total cash flows from operations | $505.79 | $739.01 | $811.66 | $617.64 |
| Investing activities | ||||
| Capital expenditures | $488.91 | $1868.94 | -$110.5 | -$10.35 |
| Investments | $263.84 | -$139.93 | $1602.32 | $1312.76 |
| Total cash flows from investing | $517.56 | $396.06 | -$3858.41 | -$2946.77 |
| Financing activities | ||||
| Dividends paid | -$615.39 | -$698.53 | -$643.47 | -$567.97 |
| Sale and purchase of stock | -$17.94 | $1051.23 | $411.1 | |
| Net borrowings | -$407 | -$591.11 | $2522.04 | $1536.24 |
| Total cash flows from financing | -$1020.33 | -$1342.52 | $2947.61 | $1401.07 |
| Effect of exchange rate | $11.4 | -$12.89 | $4.66 | $16.44 |
| Change in cash and equivalents | $3.02 | -$207.46 | -$99.15 | -$928.06 |
News
Fundamentals
| Market cap | $2.65B |
|---|---|
| Enterprise value | $12.62B |
| Shares outstanding | 598.99M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | -132.16% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.35 |
| Book/Share | 12.67 |
| Cash/Share | 0.42 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.40 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.56 |
| Quick ratio | 1.56 |